| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |